Literature DB >> 24089525

A key role for Plasmodium subtilisin-like SUB1 protease in egress of malaria parasites from host hepatocytes.

Lina Tawk1, Céline Lacroix, Pascale Gueirard, Robyn Kent, Olivier Gorgette, Sabine Thiberge, Odile Mercereau-Puijalon, Robert Ménard, Jean-Christophe Barale.   

Abstract

In their mammalian host, Plasmodium parasites have two obligatory intracellular development phases, first in hepatocytes and subsequently in erythrocytes. Both involve an orchestrated process of invasion into and egress from host cells. The Plasmodium SUB1 protease plays a dual role at the blood stage by enabling egress of the progeny merozoites from the infected erythrocyte and priming merozoites for subsequent erythrocyte invasion. Here, using conditional mutagenesis in P. berghei, we show that SUB1 plays an essential role at the hepatic stage. Stage-specific sub1 invalidation during prehepatocytic development showed that SUB1-deficient parasites failed to rupture the parasitophorous vacuole membrane and to egress from hepatocytes. Furthermore, mechanically released parasites were not adequately primed and failed to establish a blood stage infection in vivo. The critical involvement of SUB1 in both pre-erythrocytic and erythrocytic developmental phases qualifies SUB1 as an attractive multistage target for prophylactic and therapeutic anti-Plasmodium intervention strategies.

Entities:  

Keywords:  Conditional Mutagenesis; Egress; Hepatocyte; Malaria; Molecular Genetics; Plasmodium; Protease; Subtilisin

Mesh:

Substances:

Year:  2013        PMID: 24089525      PMCID: PMC3829181          DOI: 10.1074/jbc.M113.513234

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Evidence of artemisinin-resistant malaria in western Cambodia.

Authors:  Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

2.  Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism.

Authors:  Benoit Witkowski; Joel Lelièvre; María José López Barragán; Victor Laurent; Xin-zhuan Su; Antoine Berry; Françoise Benoit-Vical
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

3.  The LIM homeobox protein mLIM3/Lhx3 induces expression of the prolactin gene by a Pit-1/GHF-1-independent pathway in corticotroph AtT20 cells.

Authors:  S E Girardin; S Benjannet; J C Barale; M Chrétien; N G Seidah
Journal:  FEBS Lett       Date:  1998-07-24       Impact factor: 4.124

4.  Clonal conditional mutagenesis in malaria parasites.

Authors:  Audrey Combe; Donatella Giovannini; Teresa Gil Carvalho; Stephan Spath; Bertrand Boisson; Céline Loussert; Sabine Thiberge; Céline Lacroix; Pascale Gueirard; Robert Ménard
Journal:  Cell Host Microbe       Date:  2009-04-23       Impact factor: 21.023

5.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

6.  Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells.

Authors:  Rajesh Chandramohanadas; Paul H Davis; Daniel P Beiting; Michael B Harbut; Claire Darling; Geetha Velmourougane; Ming Yeh Lee; Peter A Greer; David S Roos; Doron C Greenbaum
Journal:  Science       Date:  2009-04-02       Impact factor: 47.728

7.  A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes.

Authors:  Taco W A Kooij; Jane M Carlton; Shelby L Bidwell; Neil Hall; Jai Ramesar; Chris J Janse; Andrew P Waters
Journal:  PLoS Pathog       Date:  2005-12-23       Impact factor: 6.823

8.  A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts.

Authors:  Ahmed S I Aly; Kai Matuschewski
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

9.  Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte.

Authors:  Andrea Ruecker; Michael Shea; Fiona Hackett; Catherine Suarez; Elizabeth M A Hirst; Katarina Milutinovic; Chrislaine Withers-Martinez; Michael J Blackman
Journal:  J Biol Chem       Date:  2012-09-14       Impact factor: 5.157

10.  A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies.

Authors:  Tania F de Koning-Ward; Rebecca A O'Donnell; Damien R Drew; Russell Thomson; Terence P Speed; Brendan S Crabb
Journal:  J Exp Med       Date:  2003-09-08       Impact factor: 14.307

View more
  18 in total

Review 1.  Advances in molecular genetic systems in malaria.

Authors:  Tania F de Koning-Ward; Paul R Gilson; Brendan S Crabb
Journal:  Nat Rev Microbiol       Date:  2015-06       Impact factor: 60.633

2.  Proteomic Analysis of the Plasmodium berghei Gametocyte Egressome and Vesicular bioID of Osmiophilic Body Proteins Identifies Merozoite TRAP-like Protein (MTRAP) as an Essential Factor for Parasite Transmission.

Authors:  Jessica Kehrer; Friedrich Frischknecht; Gunnar R Mair
Journal:  Mol Cell Proteomics       Date:  2016-07-01       Impact factor: 5.911

3.  Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.

Authors:  Elina Lidumniece; Chrislaine Withers-Martinez; Fiona Hackett; Christine R Collins; Abigail J Perrin; Konstantinos Koussis; Claudine Bisson; Michael J Blackman; Aigars Jirgensons
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-18       Impact factor: 12.779

Review 4.  Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets.

Authors:  Asrar Alam
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-03-11

5.  Computational design of protein-based inhibitors of Plasmodium vivax subtilisin-like 1 protease.

Authors:  Giacomo Bastianelli; Anthony Bouillon; Christophe Nguyen; Dung Le-Nguyen; Michael Nilges; Jean-Christophe Barale
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

6.  A Plasmodium phospholipase is involved in disruption of the liver stage parasitophorous vacuole membrane.

Authors:  Paul-Christian Burda; Matthias A Roelli; Marco Schaffner; Shahid M Khan; Chris J Janse; Volker T Heussler
Journal:  PLoS Pathog       Date:  2015-03-18       Impact factor: 6.823

Review 7.  Engineered Livers for Infectious Diseases.

Authors:  Nil Gural; Liliana Mancio-Silva; Jiang He; Sangeeta N Bhatia
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-11-22

8.  A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.

Authors:  Paco Pino; Reto Caldelari; Budhaditya Mukherjee; Juha Vahokoski; Natacha Klages; Bohumil Maco; Christine R Collins; Michael J Blackman; Inari Kursula; Volker Heussler; Mathieu Brochet; Dominique Soldati-Favre
Journal:  Science       Date:  2017-10-27       Impact factor: 47.728

9.  Conditional U1 Gene Silencing in Toxoplasma gondii.

Authors:  Manuela S Pieperhoff; Gurman S Pall; Elena Jiménez-Ruiz; Sujaan Das; Carmen Melatti; Matthew Gow; Eleanor H Wong; Joanne Heng; Sylke Müller; Michael J Blackman; Markus Meissner
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

10.  In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors.

Authors:  Simone Brogi; Simone Giovani; Margherita Brindisi; Sandra Gemma; Ettore Novellino; Giuseppe Campiani; Michael J Blackman; Stefania Butini
Journal:  J Mol Graph Model       Date:  2016-01-19       Impact factor: 2.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.